+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Autoimmune Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Autoimmune Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2024
  • 103 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 77 Pages
  • Global
From
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 176 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 632 Pages
  • Global
From
Africa Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 80 Pages
  • Africa
From
Brazil Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Brazil Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Brazil
From
China Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

China Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • China
From
France Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

France Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • France
From
Germany Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Germany Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Germany
From
Ireland Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Ireland Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Ireland
From
Japan Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Japan Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Japan
From
Russia Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Russia Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Russia
From
South Korea Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

South Korea Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • South Korea
From
United States Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

United States Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • United States
From
Vietnam Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Vietnam Anti-rheumatics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • February 2022
  • 40 Pages
  • Vietnam
From
Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 5 - Product Thumbnail Image

Frontiers in Clinical Drug Research - Anti-Allergy Agents: Volume 5

  • Book
  • April 2022
Arthritis Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Arthritis Treatment Drugs Industry Forecasts - China Focus

  • Report
  • August 2024
  • 104 Pages
  • China
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more